Login| Sign Up| Help| Contact|

Patent Searching and Data


Title:
The percutaneous absorption tablet containing Rotigotine (Transdermalcompositioncomprisingrotigotine)
Document Type and Number:
Japanese Patent JP6180520
Kind Code:
B2
Abstract:
The present invention relates to a method for preventing the formation of rotigotine crystals. More particularly, the present invention relates to a method for preventing the precipitation of rotigotine crystals, comprising a step of mixing rotigotine and one or more crystallization prevention agents selected from the group consisting of fatty alcohols, fatty acids, fatty acid esters, fatty acid amides, and the derivatives thereof, and to a transdermally absorbable preparation that comprises rotigotine and crystallization prevention agents. The method and system of the present invention enable the prevention of the precipitation of rotigotine to thus increase stability during long-term storage, and therefore can be effectively applied to the manufacture of rotigotine-containing patches or the like.

Inventors:
Kim, He-Min
Fan Yung-Yoon
Yun, Won-no
Park, Yojin
Oh, Jun-Gyo
Im john-sop
Kim, Hun-tech
Application Number:
JP2015520068A
Publication Date:
August 16, 2017
Filing Date:
July 05, 2013
Export Citation:
Click for automatic bibliography generation   Help
Assignee:
SK Chemicals Company Limited
International Classes:
A61K31/381; A61K9/70; A61K47/10; A61K47/12; A61K47/32; A61K47/34; A61P25/16; A61P43/00
Domestic Patent References:
JP2005528413A
JP2005535687A
JP2010532390A
JP2009029768A
JP2008266198A
Foreign References:
WO2008044336A1
WO1997037659A1
WO2009139411A1
Attorney, Agent or Firm:
Kihei Watanabe
Okano Isao
Yuko Tanaka
Narumi Morishima
Shinichi Nakayama
Tetsuya Imai
Ikutomi Seiichi
Koji Hirayama
Shinichiro Yamazaki